How Does Myotonic Dystrophy Affect the Heart?
At a Glance
Myotonic dystrophy often damages the heart's electrical system, increasing the risk for potentially dangerous arrhythmias and conduction blocks. Because these cardiac issues can develop silently without symptoms, routine monitoring with an annual EKG is essential to prevent severe complications.
In this answer
4 sections
Many people wonder why they need to see a cardiologist when myotonic dystrophy (DM) is primarily known as a muscle disease. The simple answer is that your heart is also a muscle, and it is uniquely vulnerable to the exact same disease processes that affect your skeletal muscles [1][2][3]. Myotonic dystrophy is a multi-system condition, and cardiac issues—specifically arrhythmias and conduction blockages—are a leading cause of severe complications and sudden mortality [4]. Because these heart problems can develop silently, proactive monitoring by a cardiologist is a critical part of your care, even if you feel perfectly fine [5][6][7]. While cardiac care is essential for all types of myotonic dystrophy, severe conduction risks and blockages are most prominent in Myotonic Dystrophy Type 1 (DM1) [8][7].
How Myotonic Dystrophy Affects the Heart
The root cause of myotonic dystrophy is an expansion of repeated DNA sequences, which causes your cells to produce abnormal, “toxic” RNA [1]. This toxic RNA traps important proteins in the cell nucleus, disrupting how genes are processed [9]. In the heart muscle, this interference specifically affects genes responsible for cardiac excitability and the electrical signals that tell your heart to beat [10][4].
Because the electrical system of the heart is compromised, patients with DM are at a high risk for cardiac conduction disease—a condition where the electrical signals that coordinate heartbeats become blocked or delayed [5][11]. This can result in:
- Arrhythmias: Irregular, too fast, or too slow heartbeats that can be life-threatening [4][8].
- Atrioventricular (AV) Blocks: Delays or interruptions in the electrical signals passing between the upper and lower chambers of the heart [5][12].
- Structural Changes: Such as left ventricular dysfunction (weakening of the heart’s main pumping chamber) or fibrosis (scarring) of the heart tissue [5][13].
The Importance of Routine Screening
It is very common for the electrical issues in the heart to progress gradually without causing any noticeable symptoms like chest pain, palpitations, or shortness of breath [5][7]. This means you cannot rely on how you feel to determine if your heart is healthy.
To prevent sudden complications, consensus guidelines strongly recommend serial, routine cardiac monitoring [7][14]. Standard screening includes:
- Annual EKG (Electrocardiogram): A quick, painless test that records the electrical signals of your heart. It checks for specific signs of conduction delays, such as a prolonged PR interval or a widened QRS complex, which act as early warning signs [11][15].
- Holter Monitoring: A portable device worn for 24 hours or more that records your heart’s activity during daily life. It is typically done at a baseline appointment and then periodically (though not necessarily annually) to catch irregular rhythms that might not happen during a brief EKG at the doctor’s office [13][7].
- Echocardiograms and Cardiac MRI: Imaging tools used to look at the structure and pumping function of your heart. Like Holter monitors, these are used periodically as recommended by your doctor based on your EKG or symptoms. Cardiac MRI is an emerging, highly sensitive way to detect early tissue changes like scarring [13][16].
When to Seek Emergency Care
While routine screenings are your safety net, it is crucial to be aware of “red flag” symptoms. If you experience unexplained fainting (syncope), near-fainting, severe dizziness, or suddenly feel your heart racing or skipping beats, seek immediate medical attention [4][6]. These could be signs of a sudden, severe arrhythmia that requires urgent, emergency treatment.
Prophylactic Pacemakers and Specialized Care
Because conduction blockages can quickly become dangerous, your cardiologist will monitor the electrical timing (intervals) on your EKG very closely [11]. If these delays cross a certain threshold, your doctor may recommend the implantation of a prophylactic pacemaker [6][17].
“Prophylactic” means preventative. The pacemaker acts as a safety net, constantly monitoring your heart rate and stepping in to deliver a small electrical impulse if your heart rate drops too low or a signal is blocked [6]. For patients at risk of rapid, dangerous rhythms, an implantable cardioverter-defibrillator (ICD) might be recommended instead, which can both pace the heart and deliver a shock to correct a severe arrhythmia [17][18]. Getting a pacemaker before symptoms occur is a proven, life-saving strategy for people with DM [6][12].
Given that the electrical aspects of the heart are so critical in this condition, it is often beneficial to be evaluated by an Electrophysiologist (EP)—a specialized cardiologist focused entirely on the heart’s electrical system—or an integrated neuro-cardiac care team [19].
Common questions in this guide
Why do I need to see a cardiologist if I have myotonic dystrophy?
What heart tests are recommended for myotonic dystrophy?
What are the warning signs of a heart problem with myotonic dystrophy?
Why might I need a pacemaker for myotonic dystrophy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What were the specific measurements of my PR and QRS intervals on my last EKG, and how have they changed over time?
- 2.Given my risk for conduction blockages, should I be referred to an Electrophysiologist (EP) rather than a general cardiologist?
- 3.What is the recommended timeline for me to receive a Holter monitor or an echocardiogram based on my specific condition?
- 4.Based on my current cardiac tests, am I approaching the threshold where a prophylactic pacemaker should be considered?
- 5.Are there any daily habits, such as caffeine intake, exercise, or stress, that I should modify to protect my heart from arrhythmias?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (19)
- 1
Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1.
Sharp L, Cox DC, Cooper TA
Muscle & nerve 2019; (60(6)):779-789 doi:10.1002/mus.26709.
PMID: 31509256 - 2
Precise small-molecule recognition of a toxic CUG RNA repeat expansion.
Rzuczek SG, Colgan LA, Nakai Y, et al.
Nature chemical biology 2017; (13(2)):188-193 doi:10.1038/nchembio.2251.
PMID: 27941760 - 3
Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy.
Sznajder ŁJ, Swanson MS
International journal of molecular sciences 2019; (20(13)) doi:10.3390/ijms20133365.
PMID: 31323950 - 4
Cardiac Involvement and Arrhythmias Associated with Myotonic Dystrophy.
McBride D, Deshmukh A, Shore S, et al.
Reviews in cardiovascular medicine 2022; (23(4)) doi:10.31083/j.rcm2304126.
PMID: 36177340 - 5
Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy.
McNally EM, Mann DL, Pinto Y, et al.
Journal of the American Heart Association 2020; (9(4)):e014006 doi:10.1161/JAHA.119.014006.
PMID: 32067592 - 6
Cardiovascular manifestations of myotonic dystrophy.
Wahbi K, Furling D
Trends in cardiovascular medicine 2020; (30(4)):232-238 doi:10.1016/j.tcm.2019.06.001.
PMID: 31213350 - 7
Risk of Cardiac Disease in a Population-Based Cohort of Myotonic Dystrophy Type 1 and Type 2 in the United States.
Johnson NE, Bhandaru V, Andrews JG, et al.
Neurology. Genetics 2025; (11(6)):e200322 doi:10.1212/NXG.0000000000200322.
PMID: 41170323 - 8
Which Is the True Epidemiology of Atrial Fibrillation in Myotonic Dystrophy Type 1 Patients?
Russo V, Papa AA, Rago A, Nigro G
Pacing and clinical electrophysiology : PACE 2016; (39(12)):1418-1419 doi:10.1111/pace.12970.
PMID: 27807876 - 9
hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologies.
Alexander MS, Hightower RM, Reid AL, et al.
Muscle & nerve 2021; (63(6)):928-940 doi:10.1002/mus.27216.
PMID: 33651408 - 10
Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.
Kim EY, Barefield DY, Vo AH, et al.
JCI insight 2019; (4(6)).
PMID: 30730308 - 11
Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1.
Joosten IBT, van Lohuizen R, den Uijl DW, et al.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2021; (23(2)):298-304 doi:10.1093/europace/euaa256.
PMID: 33150426 - 12
Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
Bienias P, Łusakowska A, Ciurzyński M, et al.
Pacing and clinical electrophysiology : PACE 2016; (39(9)):959-68 doi:10.1111/pace.12924.
PMID: 27444982 - 13
Cardiac Pathology in Myotonic Dystrophy Type 1.
Mahadevan MS, Yadava RS, Mandal M
International journal of molecular sciences 2021; (22(21)) doi:10.3390/ijms222111874.
PMID: 34769305 - 14
Myotonic dystrophy type 1: palliative care guidelines.
Willis D, Willis T, Bassie C, et al.
BMJ supportive & palliative care 2024; doi:10.1136/spcare-2023-004748.
PMID: 38253488 - 15
The current status of medical care for myotonic dystrophy type 1 in the national registry of Japan.
Yamauchi K, Matsumura T, Takada H, et al.
Muscle & nerve 2023; (67(5)):387-393 doi:10.1002/mus.27799.
PMID: 36762492 - 16
A rare case report of severe cardiomyopathy associated with myotonic dystrophy type 2.
Touma AM, Nijjar PS, Manousakis GE, Kamdar F
European heart journal. Case reports 2022; (6(3)):ytac015 doi:10.1093/ehjcr/ytac015.
PMID: 35350724 - 17
An overview of heart rhythm disorders and management in myotonic dystrophy type 1.
Gossios TD, Providencia R, Creta A, et al.
Heart rhythm 2022; (19(3)):497-504 doi:10.1016/j.hrthm.2021.11.028.
PMID: 34843968 - 18
Risk for Complications after Pacemaker or Cardioverter Defibrillator Implantations in Patients with Myotonic Dystrophy Type 1.
Sochala M, Wahbi K, Sorbets E, et al.
Journal of neuromuscular diseases 2017; (4(3)):175-181 doi:10.3233/JND-170232.
PMID: 28598855 - 19
Comprehensive Cardiovascular Management of Myotonic Dystrophy Type 1 Patients: A Report from the Italian Neuro-Cardiology Network.
Russo V, Antonini G, Massa R, et al.
Journal of cardiovascular development and disease 2024; (11(2)) doi:10.3390/jcdd11020063.
PMID: 38392277
This page explains the cardiac effects of myotonic dystrophy for educational purposes only and does not replace professional medical advice. Always consult your cardiologist or electrophysiologist regarding your specific screening and treatment needs.
Get notified when new evidence is published on Myotonic dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.